Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancer

Clinical Cancer Research

Volumn 6, Issue 8, 2000, Pages 3025-3031

  Schilsky, Richard L ^a   Eileen Dolan, M ^a   Bertucci, Donna ^a   Ewesuedo, Reginald B ^a   Vogelzang, Nicholas J ^a   Mani, Sridhar ^a   Wilson, Lynette R ^a   Ratain, Mark J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; 6 O BENZYLGUANINE; 8 HYDROXYGUANINE; CARMUSTINE;

ADULT; ADVANCED CANCER; AGED; AREA UNDER THE CURVE; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CLINICAL TRIAL; DOSE RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SOLID TUMOR; TOXICITY TESTING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARMUSTINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GUANINE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE;

EID: 0343953050     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. 6-alkylguanine-DNA alkyltransferase. Prog. Nucleic Acid Res. Mol. Biol., 57: 167-223, 1995.
2. 6-methylguanine. Biochem. Pharmacol., 43: 1101-1107, 1992.
3. 6-Methylguanine DNA methyltransferase activity in human tumors. Carcinogenesis (Lond.), 13: 1503-1507, 1992.
4. 6-alkylguanine DNA alkyltransferase and sensitivity to procarbazine in human brain tumor xenografts. J. Neurosurg., 70: 573-577, 1989.
5. Friedman, H. S., Dolan, M. E., Moschel, R. S., Pegg, A. E., Felker, G. M., Rich, J., Bigner, D. D., and Schold, S. C. Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme. J. Natl. Cancer Inst., 84: 1926-1931, 1992.
6. 6-Alkylguanine DNA alkyltransferase activity correlates with the response of human rhabdomyosarcoma xenografts to 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea. Proc. Natl. Acad. Sci. USA, 82: 2985-2989, 1985.
7. 6-alkylguanine DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumor cells. Br. J. Cancer, 67: 1299-1302, 1993.
8. 6-benzylguanine on the sensitivity of human tumor xenografts to 1-3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation. Cancer Res., 52: 1171-1175, 1992.
9. 6-alkylguanine DNA alkyltransferase. Cancer Res., 48: 1521-1527, 1988.
10. Micetich, K. S., Futscher, B., Koch, D., Fisher, R. I., and Erickson, L. C. Phase I study of streptozotocin- and carmustine-sequenced administration in patients with advanced cancer. J. Natl. Cancer Inst., 84: 256-260, 1992.
11. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc. Natl. Acad. Sci. USA, 87: 5368-5372, 1990.
12. 6-benzylguanine. Biochemistry, 32: 11998-12006, 1993.
13. 6-benzylguanine analogs on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents. Cancer Res., 51: 3367-3372, 1991.
14. 6-alkylguaine-DNA transferase correlates with potentiation of temozolomide and CCNU toxicity in human tumor cells. Br J Cancer., 67: 1299-1302, 1993.
15. 6-benzylguanine on the sensitivity of human colon tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Biochem. Pharmacol., 46: 285-290, 1993.
16. 6-benzylguaine and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in a human colon cancer xenograft completely resistant to BCNU alone. Biochem. Pharmacol., 45: 483-491, 1993.
17. 6-benzylguanine and 1,3-bis(2-cloroethyl)-1-nitrosourea. Cancer Chemother. Pharmacol., 32: 471-476, 1993.
18. 6-benzylguanine (NSC-637037) and BCNU (Carmustine NSC-409962) in male and female beagle dogs. Proc. Am. Assoc. Cancer Res., 35: 328, 1994.
19. 6-benzylguanine (NSC-637037) in mice and dogs. Proc. Am. Assoc. Cancer Res., 35: 328, 1994.
20. 6-benzylguanine for patients undergoing surgery for malignant glioma. J. Clin. Oncol., 16: 3570-3575, 1998.
21. 6-Benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair. Cancer Res., 59: 2402-2410, 1999.
22. 6-Benzylguanine in humans: metabolic, pharmacokinetic, and pharmacodynamic findings. J. Clin. Oncol., 16: 1803-1810, 1998.
23. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
24. Erickson, L. C., Bradley, M. O., Ducore, J. M., Ewig, R. A., and Kohn, K. W. DNA crosslinking and cytotoxicity in normal and transformed human cells treated with antitumor nitrosoureas. Proc. Natl. Acad. Sci. USA, 77: 467-471, 1980.